Status:
COMPLETED
Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes
Lead Sponsor:
Iuliu Hatieganu University of Medicine and Pharmacy
Conditions:
Hepato-cellular Carcinoma
Neutrophil Extracellular Trap Formation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes The goal of this clinical trial is to evaluate of the involvement of Neutrophil extracellular ...
Detailed Description
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with rising incidence in the context of chronic liver disease, viral hepatitis, non-alcoholic fatty liver ...
Eligibility Criteria
Inclusion
- Diagnosed with: hepatocellular carcinoma, or hepatic metastases
- Scheduled for elective liver surgery:
Exclusion
- Undergoing emergency surgery
- Receiving chronic immunosuppressive therapy
- Having contraindications to any of the study medications
- Diagnosed with psychiatric disorders, such as: depression, bipolar disorder, schizophrenia, having autoimmune diseases
- Suffering from corticosteroid-dependent bronchial asthma
- Diagnosed with congenital or acquired coagulation disorders
Key Trial Info
Start Date :
February 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2024
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT07207304
Start Date
February 3 2022
End Date
June 3 2024
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Institute of Gastroenterology and Hepatology Octavian Fodor
Cluj-Napoca, Cluj, Romania, 400162